← back to search

Minjie Liu

Ningbo University · CN
Area of research
Biomedical Engineering · Organic Chemistry
Research interest
Research interests include Innovative Microfluidic and Catalytic Techniques Innovation, Chemical Synthesis and Analysis, Catalytic C–H Functionalization Methods, and Pharmacogenetics and Drug Metabolism.
h-index
15
citations
703
works
68
NIH funding
primary concept
email

Recent publications

Epidemiology, genetic characteristics, and association with meteorological factors of human metapneumovirus infection in children in southern China: A 10-year retrospective study
International Journal of Infectious Diseases 2023cited by 33position: middledoi
Photo-induced 1,2-aryl migration of 2-chloro-1-arylpropanone under batch and flow conditions: Rapid, scalable and sustainable approach to 2-arylpropionic acids
Chinese Chemical Letters 2023cited by 13position: middledoi
Flow chemistry in the multi-step synthesis of natural products
Green Synthesis and Catalysis 2022cited by 60position: middledoi
Catalytic <i>Syn</i>-Selective Nitroaldol Approach to Amphenicol Antibiotics: Evolution of a Unified Asymmetric Synthesis of (−)-Chloramphenicol, (−)-Azidamphenicol, (+)-Thiamphenicol, and (+)-Florfenicol
The Journal of Organic Chemistry 2021cited by 32position: middledoi
Fully Continuous Flow Synthesis of 5-(Aminomethyl)-2-methylpyrimidin-4-amine: A Key Intermediate of Vitamin B<sub>1</sub>
Organic Process Research & Development 2021cited by 17position: middledoi
Effects and Mechanisms of Transcutaneous Electrical Acustimulation on Postoperative Recovery After Elective Cesarean Section
Neuromodulation Technology at the Neural Interface 2020cited by 19position: middledoi
Access to a Key Building Block for the Prostaglandin Family via Stereocontrolled Organocatalytic Baeyer–Villiger Oxidation
Angewandte Chemie International Edition 2019cited by 42position: middledoi
Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
Acta Pharmaceutica Sinica B 2019cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fen‐Er Chen · Fudan University6 papers (2019–2023)Meifen Jiang · Fudan University4 papers (2021–2023) · 2 papers (2021–2021)Dang Cheng · Fudan University2 papers (2021–2022)Chunlin Zhuang · Fudan University1 papers (2019–2019)Hengming Ye · Guangdong Medical College1 papers (2023–2023) · 1 papers (2021–2021)Jingyao Liang · Research Triangle Park Foundation1 papers (2023–2023)Haihui Peng · Fudan University1 papers (2019–2019)Christophe Pannecouque · KU Leuven1 papers (2019–2019)Zhenjian He · Sun Yat-sen University1 papers (2023–2023)Yongyao Tan · Sun Yat-sen University1 papers (2023–2023)Jueheng Wu · Shandong University1 papers (2023–2023)Yingtang Ning · Fudan University1 papers (2023–2023)Delin Chen · Sun Yat-sen University1 papers (2023–2023)Erik De Clercq · KU Leuven1 papers (2019–2019)Yizhe Li · Guangzhou University of Chinese Medicine1 papers (2023–2023)Kaijun Jin · Fudan University1 papers (2019–2019) · 1 papers (2022–2022)Mengfeng Li · University of Science and Technology of China1 papers (2023–2023)